ITGAX and melanoma: Furthermore, CPI-613–pretreated Lal–/– CD11c+ cells showed reduced capabilities of T cell suppression when cocultured with CD4+ T cells in vitro (Figure 4I) and tumor growth stimulation when coinjected with B16 melanoma cells subcutaneously in Lal+/+ mice (Figure 4J).